Digitisation | March 18, 2023
Lupin Digital Health reveals results of digital therapeutics study with ACS patients
The one-year-long study was aimed to evaluate the efficacy of LDH's digital therapeutics platform
The one-year-long study was aimed to evaluate the efficacy of LDH's digital therapeutics platform
Proposed combination enhances Pfizer’s position as a leading company in oncology
Chronic Kidney Disease is a growing epidemic with 850 million people affected worldwide.
Digital success is contingent on the way a company organizes itself around technology
Apixaban Tablets, 2.5 mg and 5 mg had annual sales of USD 18,876 mn in the United States (IQVIA MAT Dec. 2022).
This combination medicine is used to treat high blood pressure (hypertension).
Natco launched pomalidomide under their brand NAT-POMALIDOMIDE in strengths of 1 mg, 2 mg, 3 mg and 4 mg capsules
Amala Hospital partners with LifeSigns to provide revolutionary technology for the first time in the State
Twelve hospitals across India will be part of the network which will support the trial in India
First approval for Daiichi Sankyo and AstraZeneca’s ENHERTU in China
Subscribe To Our Newsletter & Stay Updated
